https://scholars.lib.ntu.edu.tw/handle/123456789/543795
標題: | The effectiveness and durability of ureteral tumor stent, the National Taiwan University Hospital experience | 作者: | Hung, Shih Chun I-NI CHIANG CHAO-YUAN HUANG YEONG-SHIAU PU |
關鍵字: | Obstructive uropathy | Ureteral stent | 公開日期: | 12-四月-2016 | 來源出版物: | Urological Science | 摘要: | © 2017. Purpose: We reviewed the clinical experience of using the ureteral tumor stent (Bard®, angiomed UROSOFT) in the National Taiwan University Hospital. We focused on the efficacy and durability of the ureteral tumor stent. Methods: We collected the patient data from April 2013 to April 2014. A total of 94 patients with 157 ureteral units which received ureteral tumor stent in the National Taiwan University Hospital were enrolled. We analyzed the effectiveness according to the hydronephrosis grading. The durability was counted if it did not match any of the failure criteria including: 1. Hydronephrosis upgrade, 2. Serum creatinine elevated over 150% of baseline, 3. Ipsilateral percutaneous nephrostomy insertion or failure to remove it after antegrade insertion, 4. Replacement due to clinically significant symptoms. Results: In general, 65% hydronephrosis downgrade, 25% remained stationary without severe hydronephrosis, while only 10% deteriorated or remain severe hydronephrosis. The median durability was 6.8 months. The bacteuria and size of the ureteral tumor stent were the significant factors about the durability in single variant analysis. Conclusion: The ureteral tumor stent would improve the obstructive uropathy and persist functional for an average period over half a year. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/543795 | ISSN: | 18795226 | DOI: | 10.1016/j.urols.2017.05.002 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。